SCHEMBL26463595

SCHEMBL26463595

COC(=O)/C=C/C(O)(O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.52
HCAR2 Q8TDS4 2/20 0.52
KEAP1 Q14145 1/20 0.52
ALDH1A1 P00352 6/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
RECQL P46063 1/20 0.37
MAPT P10636 4/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
TYR P14679 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
GFPT1 Q06210 1/20 0.34
TSHR P16473 1/20 0.32
TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23823763 0.82 NFE2L2 (0.52) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL3022767 0.73 NFE2L2 (0.60) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL1881404 0.73 NFE2L2 (0.60) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL901299 0.73 NFE2L2 (0.52) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
Dimethyl Fumarate SCHEMBL29110379 0.72 NFE2L2 (0.77) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL2418087 0.71 NFE2L2 (0.57) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL10350565 0.71 NFE2L2 (0.57) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL321329 0.71 NFE2L2 (0.57) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
SCHEMBL321328 0.71 NFE2L2 (0.57) NFE2L2HCAR2KEAP1ALDH1A1ALOX15
Ammonia Solution, Strong SCHEMBL27555207 0.71 NFE2L2 (0.50) NFE2L2HCAR2KEAP1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139593-A1 TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-05-04 US disclosed
US-20230139593-A1 TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139593-A1 TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME GPX4, TXNRD2, TXN2 NFE2L2 34/4885HCAR2 1367/4885KEAP1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.